|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.930 EUR | +1.74% |
|
-4.56% | -30.57% |
| Feb. 26 | Mixed European Markets as U.S. Tariff War Looms | AN |
| Feb. 25 | Mib Surpasses 47,100; Buying Spree on Mediobanca and MPS | AN |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | 1.93 | 4.02 | 5.91 | 6.06 | 3.52 | |
Return on Total Capital | 3.38 | 5.73 | 8.82 | 8.55 | 4.88 | |
Return On Equity % | 18.27 | 19.52 | -9.66 | 26.39 | 11.02 | |
Return on Common Equity | 18.27 | 19.52 | -9.66 | 26.28 | 11.02 | |
Margin Analysis | ||||||
Gross Profit Margin % | 31 | 30.64 | 31.09 | 33.58 | 31.8 | |
SG&A Margin | 17.67 | 16.29 | 15.17 | 15.23 | 16.36 | |
EBITDA Margin % | 11.2 | 13.35 | 14.66 | 16.69 | 12.8 | |
EBITA Margin % | 10.25 | 12.56 | 13.86 | 14.97 | 10.86 | |
EBIT Margin % | 5.89 | 9.46 | 11.41 | 12.54 | 8.15 | |
Income From Continuing Operations Margin % | 7.94 | 7.85 | -2.96 | 9.71 | 5.48 | |
Net Income Margin % | 7.94 | 7.85 | -2.96 | 9.66 | 5.48 | |
Net Avail. For Common Margin % | 7.94 | 7.85 | -2.96 | 9.66 | 5.48 | |
Normalized Net Income Margin | 2.96 | 6.35 | 0.54 | 8.45 | 4.86 | |
Levered Free Cash Flow Margin | 19.06 | 16 | 9.47 | -6.56 | 16.69 | |
Unlevered Free Cash Flow Margin | 20.43 | 17.79 | 10.32 | -4.1 | 18.86 | |
Asset Turnover | ||||||
Asset Turnover | 0.52 | 0.68 | 0.83 | 0.77 | 0.69 | |
Fixed Assets Turnover | 4.94 | 6.55 | 6.62 | 5.78 | 5.26 | |
Receivables Turnover (Average Receivables) | 5.64 | 7.68 | 9.27 | 8.5 | 6.92 | |
Inventory Turnover (Average Inventory) | 5.63 | 7.27 | 7.35 | 6.48 | 6.03 | |
Short Term Liquidity | ||||||
Current Ratio | 1.24 | 0.87 | 0.78 | 1.29 | 1.16 | |
Quick Ratio | 0.98 | 0.66 | 0.59 | 0.76 | 0.89 | |
Operating Cash Flow to Current Liabilities | 0.34 | 0.34 | 0.21 | 0.16 | 0.28 | |
Days Sales Outstanding (Average Receivables) | 64.94 | 47.51 | 39.36 | 42.92 | 52.92 | |
Days Outstanding Inventory (Average Inventory) | 65.06 | 50.22 | 49.65 | 56.35 | 60.73 | |
Average Days Payable Outstanding | 111.13 | 88.54 | 82.52 | 78.23 | 86.03 | |
Cash Conversion Cycle (Average Days) | 18.87 | 9.18 | 6.49 | 21.04 | 27.62 | |
Long Term Solvency | ||||||
Total Debt/Equity | 144.48 | 114.92 | 216.2 | 123.74 | 97.35 | |
Total Debt / Total Capital | 59.1 | 53.47 | 68.37 | 55.3 | 49.33 | |
LT Debt/Equity | 119.17 | 71.81 | 124.91 | 101.94 | 71.16 | |
Long-Term Debt / Total Capital | 48.74 | 33.41 | 39.5 | 45.56 | 36.06 | |
Total Liabilities / Total Assets | 75.72 | 69.54 | 78.58 | 67.53 | 63.82 | |
EBIT / Interest Expense | 2.68 | 3.31 | 8.46 | 3.19 | 2.35 | |
EBITDA / Interest Expense | 6 | 5.25 | 11.91 | 4.69 | 4.34 | |
(EBITDA - Capex) / Interest Expense | 5.68 | 4.84 | 11.18 | 4.09 | 3.83 | |
Total Debt / EBITDA | 5.21 | 3.38 | 3.95 | 3.58 | 3.38 | |
Net Debt / EBITDA | 2.33 | 1.85 | 2.62 | 2.8 | 2 | |
Total Debt / (EBITDA - Capex) | 5.5 | 3.67 | 4.21 | 4.1 | 3.83 | |
Net Debt / (EBITDA - Capex) | 2.47 | 2.01 | 2.79 | 3.21 | 2.27 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | -16.77 | 31.16 | 37.76 | 44.79 | 12.8 | |
Gross Profit, 1 Yr. Growth % | -16.01 | 30.38 | 27.72 | 57.94 | 6.9 | |
EBITDA, 1 Yr. Growth % | -41.93 | 55.94 | 24.41 | 70.07 | -13.33 | |
EBITA, 1 Yr. Growth % | -20.22 | 60.27 | 23.61 | 61.68 | -18.07 | |
EBIT, 1 Yr. Growth % | -54.15 | 110.02 | 27.35 | 65.64 | -26.55 | |
Earnings From Cont. Operations, 1 Yr. Growth % | 19.58 | 29.29 | -152.03 | -574.21 | -36.35 | |
Net Income, 1 Yr. Growth % | 19.58 | 29.29 | -152.03 | -572.13 | -36.07 | |
Normalized Net Income, 1 Yr. Growth % | -51.81 | 180.52 | -90.81 | 3.36K | -35.07 | |
Diluted EPS Before Extra, 1 Yr. Growth % | - | 29.29 | -152.4 | -491.32 | -41.86 | |
Accounts Receivable, 1 Yr. Growth % | -32.39 | 22.45 | 24.21 | 83.5 | 14.46 | |
Inventory, 1 Yr. Growth % | 3.7 | 17.15 | 50.82 | 63.41 | 0.62 | |
Net Property, Plant and Equip., 1 Yr. Growth % | 0.43 | -3.38 | 77.37 | 59.25 | 1.8 | |
Total Assets, 1 Yr. Growth % | 5.23 | -3.06 | 31.3 | 73.29 | -0.91 | |
Tangible Book Value, 1 Yr. Growth % | -11.85 | -25.53 | 60.89 | 18.85 | -27.14 | |
Common Equity, 1 Yr. Growth % | 20.21 | 21.6 | -8.29 | 162.64 | 10.41 | |
Cash From Operations, 1 Yr. Growth % | 189.08 | 39.63 | -9.4 | -23.02 | 97.69 | |
Capital Expenditures, 1 Yr. Growth % | -44.55 | 118.52 | 15.6 | 242.21 | -14.26 | |
Levered Free Cash Flow, 1 Yr. Growth % | - | 104.87 | -26.68 | -203.3 | -386.34 | |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | 100.78 | -27.44 | -159.21 | -616.16 | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 4.35 | 34.42 | 41.23 | 27.78 | |
Gross Profit, 2 Yr. CAGR % | - | 4.22 | 34.98 | 41.33 | 29.88 | |
EBITDA, 2 Yr. CAGR % | - | -4.84 | 53.61 | 43.18 | 21.31 | |
EBITA, 2 Yr. CAGR % | - | 13.08 | 56.09 | 39.03 | 14.99 | |
EBIT, 2 Yr. CAGR % | - | -1.87 | 86.84 | 42.31 | 10.18 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | 24.34 | -17.99 | 57.07 | 73.73 | |
Net Income, 2 Yr. CAGR % | - | 24.34 | -17.99 | 56.73 | 73.73 | |
Normalized Net Income, 2 Yr. CAGR % | - | 16.28 | -42.47 | 43.76 | 373.67 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | -17.99 | 43.19 | 50.84 | |
Accounts Receivable, 2 Yr. CAGR % | - | -5.9 | 18.86 | 50.97 | 44.93 | |
Inventory, 2 Yr. CAGR % | - | 5.77 | 32.92 | 56.99 | 28.23 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | -1.49 | 30.92 | 68.06 | 27.33 | |
Total Assets, 2 Yr. CAGR % | - | 1 | 12.43 | 50.84 | 31.04 | |
Tangible Book Value, 2 Yr. CAGR % | - | -18.97 | 9.46 | 38.28 | -6.94 | |
Common Equity, 2 Yr. CAGR % | - | 20.9 | 5.6 | 55.2 | 70.29 | |
Cash From Operations, 2 Yr. CAGR % | - | 100.91 | 12.47 | -16.49 | 23.36 | |
Capital Expenditures, 2 Yr. CAGR % | - | 10.08 | 58.94 | 98.9 | 71.3 | |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | 29.28 | -14.29 | 72.21 | |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | 26.67 | -35.37 | 75.18 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | 14.47 | 37.79 | 31.03 | |
Gross Profit, 3 Yr. CAGR % | - | - | 14.93 | 41.77 | 28.74 | |
EBITDA, 3 Yr. CAGR % | - | - | 11.07 | 57.25 | 21.05 | |
EBITA, 3 Yr. CAGR % | - | - | 24.8 | 56.18 | 16.49 | |
EBIT, 3 Yr. CAGR % | - | - | 16.97 | 77.07 | 14.07 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | -7 | 47.2 | 16.23 | |
Net Income, 3 Yr. CAGR % | - | - | -7 | 46.99 | 16.23 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | -45.77 | 95.25 | 10.22 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | 38.07 | 6.03 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | 0.72 | 37.38 | 37.66 | |
Inventory, 3 Yr. CAGR % | - | - | 19.05 | 42.39 | 35.36 | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | 19.84 | 39.75 | 42.2 | |
Total Assets, 3 Yr. CAGR % | - | - | 9.98 | 29.87 | 31.13 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | 1.84 | 12.51 | 11.69 | |
Common Equity, 3 Yr. CAGR % | - | - | 10.26 | 43.07 | 38.55 | |
Cash From Operations, 3 Yr. CAGR % | - | - | 54.07 | -0.88 | 11.3 | |
Capital Expenditures, 3 Yr. CAGR % | - | - | 11.89 | 105.24 | 50.25 | |
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | - | 18.75 | 28.24 | |
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | - | -2.61 | 29.37 | |
Compound Annual Growth Rate Over Five Years | ||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 19.62 | |
Gross Profit, 5 Yr. CAGR % | - | - | - | - | 20.45 | |
EBITDA, 5 Yr. CAGR % | - | - | - | - | 14.33 | |
EBITA, 5 Yr. CAGR % | - | - | - | - | 19.97 | |
EBIT, 5 Yr. CAGR % | - | - | - | - | 13.28 | |
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | 19.41 | |
Net Income, 5 Yr. CAGR % | - | - | - | - | 19.41 | |
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | 18.38 | |
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 16.5 | |
Inventory, 5 Yr. CAGR % | - | - | - | - | 22.64 | |
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | 22.78 | |
Total Assets, 5 Yr. CAGR % | - | - | - | - | 17.96 | |
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | -1.77 | |
Common Equity, 5 Yr. CAGR % | - | - | - | - | 31.2 | |
Cash From Operations, 5 Yr. CAGR % | - | - | - | - | 40.96 | |
Capital Expenditures, 5 Yr. CAGR % | - | - | - | - | 32.67 |
- Stock Market
- Equities
- DEX Stock
- Financials Dexelance S.p.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















